Thrombosis Research
Volume 124, Issue 4 , Pages 447-451, September 2009

Shear-induced global thrombosis test of native blood: Pivotal role of ADP allows monitoring of P2Y12 antagonist therapy

  • S. Saraf

      Affiliations

    • Cardiology Department, East & North Hertfordshire NHS Trust, UK
  • ,
  • D. Wellsted

      Affiliations

    • Health and Human Sciences Research Institute, University of Hertfordshire, UK
  • ,
  • S. Sharma

      Affiliations

    • Cardiology Department, East & North Hertfordshire NHS Trust, UK
  • ,
  • D.A. Gorog

      Affiliations

    • Cardiology Department, East & North Hertfordshire NHS Trust, UK
    • National Heart and Lung Institute, Imperial College, London, UK
    • Corresponding Author InformationCorresponding author. East & North Hertfordshire NHS Trust, Welwyn Garden City, Hertfordshire AL7 4HQ, United Kingdom. Tel.: +44 207 034 8934; fax: +44 207 034 8935.

Received 6 November 2008; received in revised form 20 April 2009; accepted 26 April 2009.

Abstract 

Background

It is claimed that in shear-induced platelet function tests, shear-stress is the sole agonist causing platelet activation and resultant thrombosis. However, the fact that red blood cells (RBC) are essential to achieve platelet aggregation in these tests supports recent evidence that ADP makes an important contribution to shear-induced platelet reaction.

Aim

To establish the role of ADP in shear-induced thrombosis, and investigate whether a shear-induced thrombosis test can assess ADP-receptor (P2Y12) antagonist medication.

Methods

Blood from healthy volunteers was tested using the Global Thrombosis Test (GTT), before and after clopidogrel. To investigate the importance of contact of blood with plastic, the reactive part of the tube was primed with saline. We also investigated the effect of priming the tube with water, to cause localised haemolysis and ADP release.

Results

Saline-priming prolonged occlusion times (OT) by 25% (p<0.01) confirming ADP release from platelets and RBC as a result of contact. Water-priming shortened OT, accelerating the thrombotic reaction (accelerated GTT; aGTT) (OT 379 vs. 177s, p<0.01). Clopidogrel increased OT (379 vs. 477s, p<0.01), preventing the shortening of aGTT-OT (177 vs. 362s, pre- and post-clopidogrel; p<0.01).

Conclusion

In addition to thrombin formation, ADP released from platelets and RBC in native blood subjected to high shear-stress makes an important contribution to the resultant thrombotic occlusion. The described aGTT sensitively detected the effect of clopidogrel and thus seems suitable for monitoring and individualizing ADP-receptor antagonist therapy. Parallel measurement of GTT and aGTT would allow assessment of both global thrombotic status and response to P2Y12 antagonist therapy.

Keywords: thrombosis, ADP, platelets, clopidogrel

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-3848(09)00206-0

doi:10.1016/j.thromres.2009.04.013

Thrombosis Research
Volume 124, Issue 4 , Pages 447-451, September 2009